[Histomorphologic changes in Jensen sarcoma following radiotherapy, titanocene dichloride treatment and combination therapy].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D009368:Neoplasm Transplantation; D009942:Organometallic Compounds / Q000627:therapeutic use*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D014025:Titanium / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009942:Organometallic Compounds; D014025:Titanium; C020528:titanocene dichloride
Histomorphologische Veránderungen des Jensensarkoms nach Strahlentherapie, Titanocendichloridbehandlung (TDC) und Kombinationstherapie (TDC/nachfolgende Bestrahlung).